Musculoskeletal disorder

National Safety Council to Award Up to $260,000 to Expand Grant Programs to Solve Most Common Workplace Injury

Retrieved on: 
Friday, January 19, 2024

WASHINGTON, Jan. 19, 2024 /PRNewswire/ -- Following the debut of the Research to Solutions (R2S) grant and MSD Solutions Pilot Grant in 2023, the National Safety Council is awarding up to an additional $260,000 this year through these pioneering grant programs to help uncover promising new safety solutions to prevent work-related musculoskeletal disorders, or MSDs. As a key initiative of the Council's MSD Solutions Lab, a groundbreaking strategic program established in 2021 with funding from Amazon (NASDAQ: AMZN), a total of up to $535,000 has now been committed in grants to foster innovative, transferable methods to mitigate MSDs – the most common workplace injury – across a range of sectors and workplaces.  

Key Points: 
  • "We are pleased to continue our partnership with NSC on the MSD Solutions Lab," said Sarah Rhoads, Vice President of Global Workplace Health and Safety at Amazon.
  • "The Research to Solutions and MSD Pilot Grant programs will advance research and create scalable MSD mitigation programs that help improve safety for employees on a global scale."
  • The R2S and MSDs Pilot Grant are two of several initiatives supported by the MSD Solutions Lab to achieve its goal of preventing MSDs.
  • To learn more about the grant programs and application requirements, click here .

SPEEDO WELCOMES AMERICAN PARALYMPIAN SILVER MEDALIST SWIMMER AHALYA LETTENBERGER TO THE TEAM

Retrieved on: 
Tuesday, January 16, 2024

CYPRESS, Calif., Jan. 16, 2024 /PRNewswire/ -- Speedo, the world-renowned swimwear and accessories brand, and developer of pioneering Fastskin® LZR® Intent and LZR Valor swimsuits, announces an inspiring new partnership with American Paralympic Swimmer Ahalya Lettenberger.

Key Points: 
  • CYPRESS, Calif., Jan. 16, 2024 /PRNewswire/ -- Speedo, the world-renowned swimwear and accessories brand, and developer of pioneering Fastskin® LZR® Intent and LZR Valor swimsuits, announces an inspiring new partnership with American Paralympic Swimmer Ahalya Lettenberger.
  • She also recently broke an American record in the 200 Breast at her mid-season meet for Rice University.
  • Simon Brecken, Global Senior Vice President, Speedo, expressed his excitement about the collaboration: "We are thrilled to welcome Ahalya Lettenberger to the Speedo family.
  • Ahalya Lettenberger also shared her enthusiasm about the partnership, stating, "Joining Speedo is a dream come true.

Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report

Retrieved on: 
Sunday, January 14, 2024

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a new report examining musculoskeletal injury care and reimbursement in Australia that urges health payers and providers to resolve system-wide challenges hindering positive patient pathways from primary settings through to recovery.

Key Points: 
  • Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a new report examining musculoskeletal injury care and reimbursement in Australia that urges health payers and providers to resolve system-wide challenges hindering positive patient pathways from primary settings through to recovery.
  • The Economist Impact - Musculoskeletal Injuries in Australia Report outlines the growing number of meniscal injury (MI) and rotator cuff (RC) injuries in Australia.
  • We know that access to care is dwindling, as elective surgery queues are getting bigger, and pathways are inconsistent between different clinicians and providers.
  • And second, in their access to the new and enormous amounts of data that’s coming out in this area.”
    Please see the report here: https://impact.economist.com/perspectives/health/musculoskeletal-injurie...
    1.

National Safety Council Releases Inaugural MSD Pledge Community Report on Workplace Injury Progress

Retrieved on: 
Wednesday, January 10, 2024

WASHINGTON, Jan. 10, 2024 /PRNewswire/ -- Musculoskeletal disorders, or MSDs, are the most common workplace injury, costing U.S. businesses in the private sector nearly $17 billion a year, according to the Liberty Mutual Workplace Safety Index. Recognizing the impact these injuries have on workers and businesses, the National Safety Council, with funding from Amazon (NASDAQ: AMZN), established the groundbreaking MSD Solutions Lab in 2021 to solve workplace MSDs. As a hallmark initiative of the lab, the MSD Pledge was launched in June 2022 and many of the world's leading employers have joined the global effort to reduce this pervasive safety challenge. To help monitor progress along this journey of transforming workplace safety and improving the lives of millions of workers, NSC developed the MSD Solutions Index, an annual benchmarking survey, and today released the inaugural findings in the MSD Solutions Index Pledge Community Report.

Key Points: 
  • Recognizing the impact these injuries have on workers and businesses, the National Safety Council , with funding from Amazon (NASDAQ: AMZN), established the groundbreaking MSD Solutions Lab in 2021 to solve workplace MSDs.
  • To help monitor progress along this journey of transforming workplace safety and improving the lives of millions of workers, NSC developed the MSD Solutions Index, an annual benchmarking survey, and today released the inaugural findings in the MSD Solutions Index Pledge Community Report .
  • The MSD Solutions Index provides MSD Pledge members with individualized feedback on areas of success and opportunity for improvement related to their current MSD reduction efforts and to help identify broader industry trends impacting MSD prevention efforts.
  • Recently, the Council introduced the next evolution of its industry-first call-to-action to transform workplace safety, the MSD Pledge 2.0 .

This Week in Tech News: 12 Stories You Need to See

Retrieved on: 
Friday, October 6, 2023

NEW YORK, Oct. 6, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the business technology industry stay on top of the week's most newsworthy and popular releases, here's a roundup of stories from the week that shouldn't be missed.

Key Points: 
  • Science Table by Anatomage inspires the next generation of learners with its 60+ virtual experiments in biology, chemistry, and physics.
  • "3PLs and their customers are leveraging their relationships along with technology, data, analytics and supply chain talent to increase agility and enhance success."
  • Subject Matter Experts: Access ProfNet , a database of industry experts to connect with as sources or for quotes in your articles.
  • Related Resources: Read and subscribe to our journalist- and blogger-focused blog, Beyond Bylines , for media news roundups, writing tips, upcoming events, and more.

Global Musculoskeletal Disorders Drugs Market to Surge, Projected to Reach $109.4 Billion by 2029 with 4.2% CAGR - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 13, 2023

The global Musculoskeletal Disorders Drugs Market is set to witness significant expansion, projected to reach a substantial value of $109.4 billion by 2029, with a steady Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.

Key Points: 
  • The global Musculoskeletal Disorders Drugs Market is set to witness significant expansion, projected to reach a substantial value of $109.4 billion by 2029, with a steady Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.
  • The rise in life expectancy and aging population leads to a surge in musculoskeletal diseases, boosting the demand for treatments and subsequently propelling market expansion.
  • High Prevalence of Musculoskeletal Diseases: Over 150 diseases and conditions fall under the category of musculoskeletal disorders, affecting individuals globally.
  • The prevalence of these disorders, such as arthritis, osteoarthritis, and back pain, drives the demand for drugs and treatment options.

Dental Graduates Eager To Start Their Careers Can't Skimp on Ergonomics

Retrieved on: 
Monday, June 5, 2023

CLEARWATER, Fla., June 5, 2023 /PRNewswire-PRWeb/ -- The demand for dental hygienists is predicted to increase by 9% from 2021 to 2031, faster than the average of any other occupation, with 16,300 job openings projected each coming year.(1) The demand for dentists is expected to grow by 6% during the same timeframe, with a forecast of 5,100 job openings annually.(2) Recent graduates in the dental profession are typically not thinking about their retirement; however, as dental professionals, they are at a much higher risk of developing musculoskeletal disorders (MSDs) that could cut their careers short. MSDs are injuries to the soft tissues affecting muscles, nerves, tendons, joints, and cartilage in the upper and lower limbs, neck, and lower back. MSDs can result from repetitive motion, exertion, vibration, and awkward positioning. Whether chronic or acute, exposure to these factors can be debilitating.(3) Adrian LaTrace, CEO of Boyd Industries, observes, "The first day at work for any new graduate can be both exciting and terrifying. For new arrivals to the dental field, trying to remember all those years of academic instruction and its precise practical applications can be a bit challenging at first. However, to enjoy a long career in dentistry, proper ergonomics is one of the first things to remember and the last thing to forget."

Key Points: 
  • But there are inherent health risks that must be addressed during training, after graduation, and for their entire dental career.
  • Adrian LaTrace, CEO of Boyd Industries, understands the importance of ergonomic function and design in dental equipment to accommodate the unique nature of dental provider kinetics.
  • (2) Recent graduates in the dental profession are typically not thinking about their retirement; however, as dental professionals, they are at a much higher risk of developing musculoskeletal disorders (MSDs) that could cut their careers short.
  • (4) Research for risk factors among dental practitioners discovered that dental hygienists experience even higher rates of MSDs of the shoulders and neck than dentists.

Levolta Pharmaceuticals Partners with Tabuk Pharmaceuticals for Commercialization of Investigational Osteoarthritis Therapy in Middle East and Africa

Retrieved on: 
Thursday, June 1, 2023

BETHLEHEM, Pa., June 1, 2023 /PRNewswire/ -- Levolta Pharmaceuticals , Inc. has entered into an exclusive licensing and distribution agreement for VOLT01 with Tabuk Pharmaceutical Manufacturing Company of Riyadh, Saudi Arabia, for the commercialization of an investigational osteoarthritis (OA) therapy in the Middle East and Africa (MEA) region, excluding South Africa.

Key Points: 
  • BETHLEHEM, Pa., June 1, 2023 /PRNewswire/ -- Levolta Pharmaceuticals , Inc. has entered into an exclusive licensing and distribution agreement for VOLT01 with Tabuk Pharmaceutical Manufacturing Company of Riyadh, Saudi Arabia, for the commercialization of an investigational osteoarthritis (OA) therapy in the Middle East and Africa (MEA) region, excluding South Africa.
  • Tabuk is the market leader in MEA and will be a valuable partner in fulfilling that mission."
  • Tabuk Pharmaceuticals, a fully owned subsidiary of Astra Industrial Group, will hold the marketing authorization and be responsible for registering, importing, and commercializing VOLT01 in the MEA region.
  • "At Tabuk Pharmaceuticals, we believe in our vital role to provide patients across the Middle East and Africa with unique healthcare solutions that support their wellbeing," said Mohammed Al Hagbani, CEO of Tabuk Pharmaceuticals and President of Astra Industrial Group.

Transcarent Enhances Surgery Care Experience with ViewFi Partnership

Retrieved on: 
Thursday, June 1, 2023

Transcarent , a health and care experience company that makes it easy for people to access high-quality, affordable care, announced a partnership with ViewFi , bringing world-class orthopedic and musculoskeletal care directly to patients.

Key Points: 
  • Transcarent , a health and care experience company that makes it easy for people to access high-quality, affordable care, announced a partnership with ViewFi , bringing world-class orthopedic and musculoskeletal care directly to patients.
  • ViewFi will power Transcarent’s Orthopedic Consult solution, part of the Transcarent Surgery Care experience.
  • This is another example of how the Transcarent Surgery Care experience prioritizes the needs of our Members to have access to high-quality, affordable care on their terms.”
    The patient-focused ViewFi Health technology platform delivers orthopedic exams with best-practice exam content and groundbreaking technology capabilities.
  • “ViewFi and Transcarent are aligned in our commitment to change how care is delivered, ensuring that consumers are prescribed the very best care plan from the outset.

Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia

Retrieved on: 
Monday, March 27, 2023

ENGLEWOOD CLIFFS, NJ, March 27, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc.  (Nasdaq: SILO) (the “Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it has filed a provisional patent application titled “Methods and Compositions for Pain Management.”

Key Points: 
  • Fibromyalgia is a chronic condition causing pain to the connective tissues throughout the body including muscles, ligaments, and tendons.
  • “This provisional patent application supports our multi-pronged strategy for advancing SP-26 into the clinic.
  • We believe our drug would serve a critical need in a largely inadequate treatment landscape for chronic pain including fibromyalgia,” said Eric Weisblum, Chief Executive Officer of the Company.
  • The Company’s intellectual property and technology rights for the treatment of rare diseases span over six issued and provisional patents with additional patent applications pending.